PD-DWI: Predicting response to neoadjuvant chemotherapy in invasive breast cancer with Physiologically-Decomposed Diffusion-Weighted MRI machine-learning model
Early prediction of pathological complete response (pCR) following neoadjuvant chemotherapy (NAC) for breast cancer plays a critical role in surgical planning and optimizing treatment strategies. Recently, machine and deep-learning based methods were suggested for early pCR prediction from multi-parametric MRI (mp-MRI) data including dynamic contrast-enhanced MRI and diffusion-weighted MRI (DWI) with moderate success. We introduce PD-DWI, a physiologically decomposed DWI machine-learning model to predict pCR from DWI and clinical data. Our model first decomposes the raw DWI data into the various physiological cues that are influencing the DWI signal and then uses the decomposed data, in addition to clinical variables, as the input features of a radiomics-based XGBoost model. We demonstrated the added-value of our PD-DWI model over conventional machine-learning approaches for pCR prediction from mp-MRI data using the publicly available Breast Multi-parametric MRI for prediction of NAC Response (BMMR2) challenge. Our model substantially improves the area under the curve (AUC), compared to the current best result on the leaderboard (0.8849 vs. 0.8397) for the challenge test set. PD-DWI has the potential to improve prediction of pCR following NAC for breast cancer, reduce overall mp-MRI acquisition times and eliminate the need for contrast-agent injection.
Code (1)
Tasks
PredictionMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Automated Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy from DWI Data
Effective surgical planning for breast cancer hinges on accurately predicting pathological complete response (pCR) to neoadjuvant chemotherapy (NAC). Diffusion-weighted MRI (DWI) and machine learning offer a non-invasive…
Image SegmentationSegmentationSemantic SegmentationTumor SegmentationUsing Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction
In 2020, 685,000 deaths across the world were attributed to breast cancer, underscoring the critical need for innovative and effective breast cancer treatment. Neoadjuvant chemotherapy has recently gained popularity as a…
Deep learning-based prediction of response to HER2-targeted neoadjuvant chemotherapy from pre-treatment dynamic breast MRI: A multi-institutional validation study
Predicting response to neoadjuvant therapy is a vexing challenge in breast cancer. In this study, we evaluate the ability of deep learning to predict response to HER2-targeted neo-adjuvant chemotherapy (NAC) from pre-tre…
Deep LearningConvolutional Restricted Boltzmann Machine Based-Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
We proposed a novel convolutional restricted Boltzmann machine CRBM-based radiomic method for predicting pathologic complete response (pCR) to neoadjuvant chemotherapy treatment (NACT) in breast cancer. The method consis…
feature selectionPredictionA two-stage dual-task learning strategy for early prediction of pathological complete response to neoadjuvant chemotherapy for breast cancer using dynamic contrast-enhanced magnetic resonance images
Rationale and Objectives: Early prediction of pathological complete response (pCR) can facilitate personalized treatment for breast cancer patients. To improve prediction accuracy at the early time point of neoadjuvant c…
Prediction